| TEHELMSA GLAXO GROUP LIMITED
2156113 14 Oct 2021 | on 26 Jul 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy. | | | TESA UROVANT SCIENCES GMBH
2111623 12 Apr 2021 | on 31 Dec 1969 | Class 038 Class 038 Communications Services Providing on-line and social media chat rooms for transmission of messages among computer users concerning disease prevention, identification, and treatment education relating to urological, metabolic, urinary tract systems, bladder, and reproductive organ diseases, disorders, pathologies, and medical conditions; peer-to-peer network computer services, namely, electronic transmission of audio, video and other data and documents among computers, all of the audio, video and other data and documents relating to preventing, identifying and treating urological, metabolic, urinary tract systems, bladder, and reproductive organ diseases, disorders, pathologies, and medical conditions; providing on-line and social media chat rooms for transmission of messages among computer users concerning the fields of biological and pharmaceutical preparations; peer-to-peer network computer services, namely, electronic transmission of audio, video and other data and documents among computers, all of the audio, video and other data and documents relating to the fields of biological and pharmaceutical preparations. Class 041 Class 041 Education and Entertainment Services Providing educational information in the fields of preventing, identifying and treating urological, metabolic, and urinary tract systems, bladder and reproductive organ diseases, disorders, pathologies, and medical conditions for medical purposes. Class 044 Medical, Beauty & Agricultural Services Provision of health information and medical information all for treatment and diagnostic purposes; provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, conditions, disorders and pathologies; providing health care advice and medical advice in the fields of preventing, identifying and treating urological, metabolic, and urinary tract systems, bladder and reproductive organ diseases, disorders, pathologies, and medical conditions; providing medical and physical health advice in the fields of biological and pharmaceutical preparations for medical purposes. | | | TESSA OXFORD GENETICS LTD
2101552 25 Feb 2021 | on 16 Aug 2022 | Class 001 Class 001 Chemical Products Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human or animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human or animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry. Class 005 Class 005 Pharmaceutical Products Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human or animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes. Class 042 Computer & Software Services & Scientific Services Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of antibodies; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services. | | | TESTAROSSA ROTKÄPPCHEN-MUMM SEKTKELLEREIEN GMBH
2055045 23 Jul 2020 | on 25 Oct 2022 | Class 032 Class 032 Light Beverage Products Non-alcoholic beverages. Class 033 Class 033 Wines and Spirits Products Alcoholic beverages (except beers). | | | TESSA FENO SCARL
2002374 28 Nov 2019 | on 12 Oct 2022 | Class 031 Class 031 Natural Agricultural Products Live apple trees, apple tree seeds, and cuttings from apple trees for grafting purposes; fresh fruit namely, apples. | | | TERRESA SHENZHEN TIANQIN TECHNOLOGY CO.LTD
1986973 26 Sep 2019 | on 27 Jul 2022 | Class 003 Class 003 Cosmetics and Cleaning Products Eyeliner; eyeshadow; facial cream; false eyelashes; hair dyes; lipsticks; mascara; nail art stickers; nail glitter; nail polish pens. | | | TERRESA SHENZHEN TIANQIN TECHNOLOGY CO.LTD
1986974 26 Sep 2019 | on 27 Jul 2022 | Class 021 Class 021 Houseware and Glass Products Cosmetic brushes; cosmetic spatulas; electric combs; eyebrow brushes; eyelash brushes; fitted vanity cases; foam toe separators for use in pedicures; large-toothed combs for the hair; make-up brushes; make-up sponges; nail brushes; perfume sprayers; powder compacts; powder puffs; shaving brushes; toilet cases; toilet sponges. | | | TERROSA RICHTER GEDEON NYRT.
1920659 18 Sep 2018 | on 16 Nov 2021 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation for the treatment of osteoporosis, namely, teriparatide | | | TERROSA RICHTER GEDEON NYRT.
1920654 18 Sep 2018 | on 22 Feb 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation for the treatment of osteoporosis, namely, teriparatide | | | TESSA NORIKA NORDRING KARTOFFELZUCHT UND VERMEHRUNGS GMBH
987196 05 Dec 2017 | on 02 Jun 2020 | Class 031 Class 031 Natural Agricultural Products Agricultural, horticultural and forestry | |